Infectious Diseases Society of America

In CID, Margot Combet, MD, and colleagues assess the prevalence of Human Herpesvirus-6 (HHV-6) disease in ICU patients with HHV-6 DNAemia, 2) identify risk factors for HHV-6 disease and 3) investigate its association with mortality. https://lnkd.in/eVMEJF96

DYK? The Leadership Institute currently offers two tailored leadership development pathways for ID and HIV specialists: Community of Leaders, a hybrid program designed for mid- to senior-career professionals, and Rising Leaders, a fully online initiative geared toward early-career professionals. Learn more (https://bit.ly/3YJpPsj) and sign up on the interest form to be notified when applications open for your program of interest: https://bit.ly/4ivv3PA

IDWeek is proud to offer several travel awards acknowledging distinguished, quality scientific research to be presented at the conference! All cases accepted for oral presentation will receive an $800 travel award. Abstract submitters can apply for seven different award categories to help fund their IDWeek experience. Learn more: https://lnkd.in/eP6sChfh

The ID Clinical Bootcamp for APPs is now available as an accredited course on the IDSA Academy! This four-hour course offers an overview of foundational and progressive topics relevant to APPs practicing in the ID field. Learn more: https://bit.ly/4j7EIwN

Clinicians: Make #sexualhealth a standard part of your practice with these resources: https://bit.ly/4hYKrU7 #TalkTestTreat #STIweek

Not only does stopping antiretrovirals affect people who are living with HIV, but they also impact our work on HIV prevention, says IDSA board member Maximo O. Brito, MD. Our full press briefing on the impact of #HIV funding cuts: https://lnkd.in/enXiseNB

In JID, Esperanza Muñoz-Muela and colleagues analyze the impact of tenofovir disoproxil fumarate plus emtricitabine (TDF/FTC)–based PrEP on mitochondria of subjects at high risk of HIV type 1 infection. https://lnkd.in/efTVn-hH

In honor of #STIWeek, take IDSA’s recently updated Hepatitis C MOC Module, a tool for self-evaluation of medical knowledge in Hepatitis C: https://lnkd.in/efiAySt6

In CID, Michael R Hodges and colleagues evaluated fosmanogepix (FMGX) treatment in invasive mold diseases (IMDs) by Aspergillus spp. and rare molds in adults with limited treatment options. https://lnkd.in/ew_yDXgP

The termination of clinical care programs in Africa will lead to countless new infant infections and deaths in mothers, children and families, warns IDSA member Lynne M. Mofenson, MD. Our full press briefing on the impact of #HIV funding cuts: https://lnkd.in/enXiseNB